Page last updated: 2024-08-21

cyclopentane and Lymphoma, Mantle-Cell

cyclopentane has been researched along with Lymphoma, Mantle-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barth, MJ; Czuczman, MS; Czuczman, NM; Frys, SE; Gu, J; Hernandez-Ilizaliturri, FJ; Hu, Q; Klener, P; Liu, S; Mavis, C; Neppalli, V; Vockova, P	1

Other Studies

1 other study(ies) available for cyclopentane and Lymphoma, Mantle-Cell

Article	Year
Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo. Blood, 2016, Mar-03, Volume: 127, Issue:9 Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Separation; Cell Survival; Cyclopentanes; Enzyme Inhibitors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Mantle-Cell; Mice, SCID; NEDD8 Protein; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Rituximab; Small Molecule Libraries; Ubiquitins	2016

Article

Year

Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo.

Blood, 2016, Mar-03, Volume: 127, Issue:9

Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Separation; Cell Survival; Cyclopentanes; Enzyme Inhibitors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Mantle-Cell; Mice, SCID; NEDD8 Protein; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Rituximab; Small Molecule Libraries; Ubiquitins

2016